- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03824600
Physiological Patterns of Coronary Artery Disease
March 27, 2020 updated by: Jeroen Sonck, Onze Lieve Vrouw Hospital
Registry of patients undergoing invasive fractional flow reserve measurement using a motorized device.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
A prospective registry of patients undergoing clinically indicated coronary angiography with fractional flow reserve evaluation for vessels with intermediate coronary lesions defined as visual diameter stenosis between 30% and 70%.
A motorized fractional flow reservepullback evaluation will be performed at the discretion of the operators.
The objective of the present study is to describe the physiological patterns of coronary artery disease using motorized coronary pressure pullbacks during continuous hyperemia in patients with stable coronary artery disease.
Study Type
Observational
Enrollment (Actual)
117
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Brussels, Belgium, 1090
- University of Brussels
-
-
West Flanders
-
Aalst, West Flanders, Belgium, 9300
- OLV Aalst
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (ADULT, OLDER_ADULT)
Accepts Healthy Volunteers
N/A
Genders Eligible for Study
All
Sampling Method
Probability Sample
Study Population
Patients undergoing clinically indicated coronary angiography and fractional flow reserve evaluation for intermediate coronary lesions defined as visual diameter stenosis between 30% and 70%
Description
Inclusion Criteria:
- Stable coronary artery disease
Exclusion Criteria:
- acute coronary syndromes
- previous coronary artery bypass grafting
- significant valvular disease
- severe obstructive pulmonary disease or asthma bronchial
- severe tortuosity or severe calcification
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Physiological Patterns of Coronary Artery Disease (i.e. focal, diffuse or combined)
Time Frame: Immediate post-procedure. No follow-up is schedule for this trial.
|
Describe the physiological patterns of coronary artery disease using motorized coronary pressure pullbacks during continuous hyperemia in patients with stable coronary artery disease.
A pullback device adapted to grip the coronary pressure wire with a speed of 1 mm/sec during continued pressure recording will be used.
A fractional flow reserve value every 100 microns will be extracted from the pressure tracing and plotted against the length to generate a pullback curve.
Fractional flow reserve will be defined as the ratio of the moving average of the proximal and distal coronary pressures.
The patterns of physiological disease will be classified as focal or diffuse according to the visual inspection of the fractional flow reserve pullback curve.
The patterns of coronary artery disease will be reported as a focal, diffuse or combined pattern (i.e.
focal and diffuse).
|
Immediate post-procedure. No follow-up is schedule for this trial.
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Classification of the physiological patterns of coronary artery disease using a quantitative metric
Time Frame: Immediate post-procedure. No follow-up is schedule for this trial.
|
Based on the data obtained using the fractional flow reserve pullbacks and conventional coronary angiography a quantitative classification of the physiological pattern of coronary artery disease based on the functional contribution of the epicardial lesion (i.e.
lesion-related pressure drop) with respect to the total vessel fractional flow reserve will be explored.
|
Immediate post-procedure. No follow-up is schedule for this trial.
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
General Publications
- Argacha JF, Decamp J, Vandeloo B, Babin D, Lochy S, Van den Bussche K, de Hemptinne Q, Xaplanteris P, Magne J, Segers P, Cosyns B. Guiding Myocardial Revascularization by Algorithmic Interpretation of FFR Pullback Curves: A Proof of Concept Study. Front Cardiovasc Med. 2021 Mar 11;8:623841. doi: 10.3389/fcvm.2021.623841. eCollection 2021.
- Collet C, Sonck J, Vandeloo B, Mizukami T, Roosens B, Lochy S, Argacha JF, Schoors D, Colaiori I, Di Gioia G, Kodeboina M, Suzuki H, Van 't Veer M, Bartunek J, Barbato E, Cosyns B, De Bruyne B. Measurement of Hyperemic Pullback Pressure Gradients to Characterize Patterns of Coronary Atherosclerosis. J Am Coll Cardiol. 2019 Oct 8;74(14):1772-1784. doi: 10.1016/j.jacc.2019.07.072.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (ACTUAL)
November 24, 2017
Primary Completion (ACTUAL)
August 30, 2019
Study Completion (ACTUAL)
September 30, 2019
Study Registration Dates
First Submitted
January 27, 2019
First Submitted That Met QC Criteria
January 30, 2019
First Posted (ACTUAL)
January 31, 2019
Study Record Updates
Last Update Posted (ACTUAL)
March 30, 2020
Last Update Submitted That Met QC Criteria
March 27, 2020
Last Verified
March 1, 2020
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- CRI-0002
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Coronary Artery Disease
-
Infirmerie Protestante de LyonRecruitingCoronary Artery Bypass | Coronary Artery Disease(CAD) | Off Pump Coronary Artery Bypass Surgery | Hemodynamic Optimization | Hemodynamic Management | Off Pump Coronary Artery Bypass Graft | Coronary Artery Disease With Need for Bypass Surgery | NoradrenalineFrance
-
Shanghai Bluesail Boyuan Medical Technology Co....Not yet recruitingCoronary Artery Disease | Coronary Artery Calcification | Severe Coronary Artery DiseaseChina
-
I.R.C.C.S Ospedale Galeazzi-Sant'AmbrogioCompletedCoronary Artery Disease (CAD) | Atherosclerosis of Coronary ArteryItaly
-
Scitech Produtos Medicos SANot yet recruitingCoronary Artery Disease (CAD) | Multivessel Coronary Artery Disease | Complex Coronary Lesions | Calcific Coronary Arteriosclerosis | Small Vessel Ischemic Disease | Stenosis CoronaryBrazil
-
Istanbul Mehmet Akif Ersoy Educational and Training...Bakirkoy Dr. Sadi Konuk Research and Training Hospital; Ege University; Istanbul... and other collaboratorsActive, not recruitingCoronary Artery Disease (CAD) | Coronary Bifurcation Lesion | Left Main Coronary Artery StenosisTurkey (Türkiye)
-
University Medical Centre LjubljanaRecruitingCoronary Artery Disease With Myocardial InfarctionSlovenia
-
EBI Anti Sepsis BVCR2O B.V.Not yet recruitingCoronary Artery Disease (CAD) | Coronary Artery Bypass Graft Surgery(CABG)United States, Netherlands, Belgium, United Kingdom
-
Elixir Medical CorporationIstituto Clinico HumanitasActive, not recruitingCoronary Artery Disease | Chronic Total Occlusion of Coronary Artery | Multi Vessel Coronary Artery Disease | Bifurcation of Coronary Artery | Long Lesions Coronary Artery DiseaseItaly
-
Mahidol UniversityThe Princess Mantarop Kamalas Foundation, The Nurses' Association of Thailand and other collaboratorsActive, not recruitingCoronary Artery Disease (CAD) | Postoperative Recovery | Coronary Artery Bypass Graft (CABG)Thailand
-
Shunmei MedicalNot yet recruitingCalcified Coronary Artery Disease | Coronary Arterial DiseasePoland, France, Spain
Clinical Trials on Fractional Flow Reserve Motorized Pullback
-
Seoul National University HospitalUnknownCoronary Artery DiseaseKorea, Republic of
-
University Hospital of FerraraSocietà Italiana di Cardiologia InvasivaCompleted
-
Peking University First HospitalRainmed Ltd., Suzhou, ChinaRecruitingCoronary Artery Disease | Percutaneous Coronary Intervention | Stable Angina Pectoris | Unstable Angina Pectoris | Coronary Stenosis | Acute Myocardial Infarction | Myocardial Ischaemia | Coronary Circulation | Asymptomatic IschemiaChina
-
Volcano CorporationCompletedCoronary DiseaseBelgium
-
The Catholic University of KoreaActive, not recruiting
-
University of GlasgowWithdrawnCoronary Artery Disease | Coronary Artery Bypass Surgery | Fracational Flow Reserve
-
Clinyx, LLCVolcano CorporationCompletedCoronary Artery Disease
-
University Hospital of FerraraCompleted
-
Seoul National University HospitalUlsan University Hospital; Seoul National University Bundang Hospital; Inje University and other collaboratorsRecruitingCoronary Artery DiseaseKorea, Republic of
-
Shanghai Zhongshan HospitalNot yet recruitingCoronary Artery Disease | In Stent Restenosis | Drug Eluting Stent